市场调查报告书
商品编码
1503397
至 2030 年微创手术市场预测:按产品类型、应用、最终用户和地区分類的全球分析Minimally Invasive Surgery Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球微创手术市场规模达 819 亿美元,预计预测期内复合年增长率为 13.0%,到 2030 年将达到 1,705 亿美元。
微创手术利用腹腔镜和机器人系统等先进技术,透过小切口进行手术操作,减少对身体的创伤。与传统的开放性手术相比,这种方法可以实现更快的恢復时间、更少的疼痛、更少的疤痕以及更低的併发症。技术进步、患者对微创手术的偏好增加以及 MIS 技术在各个医疗领域的不断扩大应用正在推动成长。
据欧洲心臟学会 (ESC) 称,与传统的心臟直视手术相比,经导管主动脉瓣置换术(TAVR) 等微创心血管手术由于风险更低、恢復时间更快而变得越来越受欢迎。
慢性病增加
心血管疾病、癌症和糖尿病等慢性疾病的盛行率不断上升,推动了对微创手术的需求。这些手术恢復时间更快,感染风险更低,术后疼痛更少,使其成为患者和医疗保健提供者的首选。随着世界人口老化和慢性病的增加,对微创手术技术的需求预计将大幅成长。
设备和流程高成本
机器人辅助手术系统和高清成像设备等先进技术价格昂贵,对于小型医疗机构和低收入地区的患者来说难以取得。这些成本可能会限制微创技术的采用,特别是在医疗保健预算有限的新兴国家。
加大医疗保健投资
增加对医疗基础设施和技术进步的投资是微创手术市场的重大机会。政府和私人组织正在增加对医疗保健计划的资助,例如先进手术器械的开发和医疗专业人员的培训计划。这些投资预计将提高微创手术的可及性和效率,并推动市场成长。
併发症的风险
儘管微创手术有好处,但也存在风险,包括麻醉併发症、感染疾病和周围组织的意外併发症。这些潜在的併发症可能会阻止患者和医疗保健提供者选择微创技术。此外,执行这些程序需要专门的培训和专业知识,这可能会限制采用并对市场成长构成威胁。
COVID-19的爆发对微创手术市场产生了重大影响。为了优先考虑 COVID-19 患者,选择性手术被推迟或取消,导致需求暂时下降。然而,这场大流行也凸显了微创手术对于缩短住院时间和尽量减少病患感染疾病的重要性。
腹腔镜设备领域预计将在预测期内成为最大的领域
腹腔镜器械细分市场预计将在预测期内创下最大的市场占有率,因为它广泛应用于胃肠道、妇科和泌尿系统等各种外科手术。这些器械具有精确性、缩短恢復时间和最小化疤痕,使其深受外科医生和患者的欢迎。腹腔镜技术的不断进步和腹腔镜手术的增加正在推动该领域的成长。
预计门诊手术中心产业在预测期内复合年增长率最高
门诊手术中心(ASC)领域预计在预测期内复合年增长率最高。 ASC 为传统的医院手术提供了一种经济高效且方便的替代方案,从而缩短了手术时间并加快了患者康復速度。对门诊手术的日益偏好和微创技术的进步正在推动 ASC 的快速成长。此外,ASC的增加和有利的报销政策也有助于该行业的扩张。
由于其先进的医疗基础设施、创新手术技术的高采用率以及主要市场参与者的存在,北美在微创手术市场占据主导地位。该地区完善的医疗保健体系和对研发的大量投资使其在市场上占有最大份额。此外,慢性病的高盛行率和微创手术需求的增加也推动了北美市场的成长。
由于医疗保健支出的增加、微创手术意识的增强以及医疗基础设施的改善,亚太地区的微创手术市场预计将快速成长。中国、印度和日本等国家正在大力投资医疗保健和技术进步,预计将推动微创手术的采用。医疗旅游业的成长和慢性病的流行也促进了该地区的高复合年增长率。
According to Stratistics MRC, the Global Minimally Invasive Surgery Market is accounted for $81.9 billion in 2024 and is expected to reach $170.5 billion by 2030 growing at a CAGR of 13.0% during the forecast period. Minimally Invasive Surgery involves performing surgical procedures through small incisions, utilizing advanced technologies like laparoscopes and robotic systems, to reduce trauma to the body. This approach leads to shorter recovery times, less pain, reduced scarring, and a lower risk of complications compared to traditional open surgery. The growth is driven by technological advancements, increasing patient preference for less invasive procedures, and the expanding applications of MIS techniques across various medical fields, resulting in their widespread adoption and development.
According to the European Society of Cardiology (ESC), minimally invasive cardiac surgeries, such as transcatheter aortic valve replacement (TAVR), have become increasingly popular due to their lower risk and shorter recovery times compared to traditional open-heart surgeries.
Increasing prevalence of chronic diseases
The rising incidence of chronic diseases such as cardiovascular disorders, cancer, and diabetes is driving the demand for minimally invasive surgeries. These procedures offer reduced recovery times, lower risk of infection, and less postoperative pain, making them a preferred choice for both patients and healthcare providers. As the global population ages and the prevalence of chronic conditions increases, the demand for minimally invasive surgical techniques is expected to grow significantly.
High cost of equipment and procedures
Advanced technologies such as robotic-assisted surgery systems and high-definition imaging devices are expensive, making them less accessible to smaller healthcare facilities and patients in low-income regions. These costs can limit the adoption of minimally invasive techniques, particularly in developing countries where healthcare budgets are constrained.
Increasing investment in healthcare
Growing investments in healthcare infrastructure and technological advancements present significant opportunities for the minimally invasive surgery market. Governments and private entities are increasingly funding healthcare projects, including the development of advanced surgical tools and training programs for medical professionals. These investments are expected to enhance the accessibility and efficiency of minimally invasive procedures, driving market growth.
Risk of complications
Despite the benefits, minimally invasive surgeries carry risks such as complications from anesthesia, infections, and accidental damage to surrounding tissues. These potential complications can deter patients and healthcare providers from opting for minimally invasive techniques. Additionally, the need for specialized training and expertise to perform these procedures can limit their widespread adoption, posing a threat to market growth.
The COVID-19 pandemic significantly impacted the minimally invasive surgery market. Elective surgeries were postponed or canceled to prioritize Covid-19 patients, leading to a temporary decline in demand. However, the pandemic also highlighted the importance of minimally invasive techniques in reducing hospital stays and minimizing patient exposure to infections, which is expected to drive long-term growth in the market.
The laparoscopic instruments segment is expected to be the largest during the forecast period
The laparoscopic instruments segment is expected to register largest market share during the forecast period due to their widespread use in various surgical procedures, including gastrointestinal, gynecological, and urological surgeries. These instruments offer precision, reduced recovery times, and minimal scarring, making them highly popular among surgeons and patients. The continuous advancements in laparoscopic technology and the increasing number of laparoscopic procedures are driving the growth of this segment.
The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period
The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period. ASCs offer cost-effective and convenient alternatives to traditional hospital-based surgeries, with shorter procedure times and faster patient recovery. The growing preference for outpatient surgeries, coupled with advancements in minimally invasive techniques, is driving the rapid growth of ASCs. Additionally, the increasing number of ASCs and favorable reimbursement policies are contributing to the segment's expansion.
North America is positioned to dominate the minimally invasive surgery market due to its advanced healthcare infrastructure, high adoption of innovative surgical technologies, and the presence of key market players. The region's well-established healthcare system and significant investments in research and development contribute to its leading market share. Additionally, the high prevalence of chronic diseases and the increasing demand for minimally invasive procedures further drive market growth in North America.
The Asia Pacific region anticipates rapid growth in the minimally invasive surgery market, driven by the increasing healthcare expenditure, rising awareness about minimally invasive techniques, and improving healthcare infrastructure. Countries like China, India, and Japan are witnessing significant investments in healthcare and technological advancements, which are expected to boost the adoption of minimally invasive surgeries. The growing medical tourism industry and the increasing prevalence of chronic diseases also contribute to the region's high CAGR.
Key players in the market
Some of the key players in Minimally Invasive Surgery Market include Medtronic plc, Johnson & Johnson (Ethicon), Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew plc, Zimmer Biomet Holdings, Inc., Intuitive Surgical, Inc., Abbott Laboratories, B. Braun Melsungen AG, ConMed Corporation, Karl Storz SE & Co. KG, Cook Medical, Applied Medical Resources Corporation, Richard Wolf GmbH, FUJIFILM Holdings Corporation, HOYA Corporation, Teleflex Incorporated, Arthrex, Inc. and NuVasive, Inc.
In March 2023, Medtronic received FDA clearance for its Steerable Flex Robotic Clip Applier used with the Hugo system for minimally invasive gynecologic procedures.
In January 2023, Ethicon launched the ECHELON+ Stapler for minimally invasive colorectal, gastric, and thoracic surgeries.
In January 2023, Boston Scientific received FDA approval for its EXALT Model D Single-Use Duodenoscope for minimally invasive endoscopic procedures.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.